Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Allen

Showing results (181-190 of 187) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 187 results.
Molecular Therapy. Nucleic Acids|November 8, 2022
Chimeric mRNA-based COVID-19 vaccine induces protective immunity against Omicron and Delta variantsQidong Hu, Ying Zhao, Namir Shaabani, et al.
Pain|December 11, 2012
A standard database format for clinical trials of pain treatments: an ACTTION-CDISC initiativeRobert H Dworkin, Robert Allen, Stephen Kopko, et al.
Annals of Neurology|March 13, 2008
A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophyKathryn R Wagner, James L Fleckenstein, Anthony A Amato, et al.
Med (New York, N.Y.)|February 10, 2024
Olgotrelvir, a dual inhibitor of SARS-CoV-2 M<sup>pro</sup> and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19Long Mao, Namir Shaabani, Xiaoying Zhang, et al.
Med (New York, N.Y.)|January 5, 2024
Olgotrelvir, a dual inhibitor of SARS-CoV-2 M<sup>pro</sup> and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19Long Mao, Namir Shaabani, Xiaoying Zhang, et al.
Med (New York, N.Y.)|August 31, 2022
Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariantsJ Andrew Duty, Thomas Kraus, Heyue Zhou, et al.
G3 (Bethesda, Md.)|March 6, 2015
Drosophila muller f elements maintain a distinct set of genomic properties over 40 million years of evolutionWilson Leung, Christopher D Shaffer, Laura K Reed, et al.
Pageof 19

Showing results (181-190 of 187) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 187 results.
Molecular Therapy. Nucleic Acids|November 8, 2022
Chimeric mRNA-based COVID-19 vaccine induces protective immunity against Omicron and Delta variantsQidong Hu, Ying Zhao, Namir Shaabani, et al.
Pain|December 11, 2012
A standard database format for clinical trials of pain treatments: an ACTTION-CDISC initiativeRobert H Dworkin, Robert Allen, Stephen Kopko, et al.
Annals of Neurology|March 13, 2008
A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophyKathryn R Wagner, James L Fleckenstein, Anthony A Amato, et al.
Med (New York, N.Y.)|February 10, 2024
Olgotrelvir, a dual inhibitor of SARS-CoV-2 M<sup>pro</sup> and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19Long Mao, Namir Shaabani, Xiaoying Zhang, et al.
Med (New York, N.Y.)|January 5, 2024
Olgotrelvir, a dual inhibitor of SARS-CoV-2 M<sup>pro</sup> and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19Long Mao, Namir Shaabani, Xiaoying Zhang, et al.
Med (New York, N.Y.)|August 31, 2022
Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariantsJ Andrew Duty, Thomas Kraus, Heyue Zhou, et al.
G3 (Bethesda, Md.)|March 6, 2015
Drosophila muller f elements maintain a distinct set of genomic properties over 40 million years of evolutionWilson Leung, Christopher D Shaffer, Laura K Reed, et al.
Pageof 19